vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and FONAR CORP (FONR). Click either name above to swap in a different company.
Avidia Bancorp, Inc. is the larger business by last-quarter revenue ($26.8M vs $25.5M, roughly 1.0× FONAR CORP). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs 8.0%, a 14.9% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $-227.0K).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
AVBC vs FONR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $25.5M |
| Net Profit | $5.3M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | 33.3% | 13.5% |
| Net Margin | 22.9% | 8.0% |
| Revenue YoY | — | 2.4% |
| Net Profit YoY | — | 4.7% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | $25.5M | ||
| Q3 25 | $28.0M | $26.0M | ||
| Q2 25 | $25.9M | $27.3M | ||
| Q1 25 | $22.9M | $27.2M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | — | $25.9M | ||
| Q1 24 | — | $25.7M |
| Q4 25 | $5.3M | $2.1M | ||
| Q3 25 | $-907.0K | $2.3M | ||
| Q2 25 | $3.9M | $729.3K | ||
| Q1 25 | $-11.6M | $2.5M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $830.4K | ||
| Q1 24 | — | $1.9M |
| Q4 25 | 33.3% | 13.5% | ||
| Q3 25 | -7.0% | 14.1% | ||
| Q2 25 | 19.4% | 5.3% | ||
| Q1 25 | -72.0% | 15.2% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 16.8% |
| Q4 25 | 22.9% | 8.0% | ||
| Q3 25 | -3.2% | 8.7% | ||
| Q2 25 | 15.0% | 2.7% | ||
| Q1 25 | -50.5% | 9.2% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.05 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $121.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $379.0M | $176.9M |
| Total Assets | $2.8B | $217.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | $121.0K | ||
| Q3 25 | $208.3M | $122.0K | ||
| Q2 25 | $592.5M | $56.5M | ||
| Q1 25 | — | $123.0K | ||
| Q4 24 | — | $121.0K | ||
| Q3 24 | — | $136.0K | ||
| Q2 24 | — | $56.5M | ||
| Q1 24 | — | $134.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
| Q4 25 | $379.0M | $176.9M | ||
| Q3 25 | $372.0M | $174.9M | ||
| Q2 25 | $191.4M | $172.6M | ||
| Q1 25 | $186.1M | $171.9M | ||
| Q4 24 | — | $169.8M | ||
| Q3 24 | — | $168.7M | ||
| Q2 24 | — | $166.0M | ||
| Q1 24 | — | $165.8M |
| Q4 25 | $2.8B | $217.2M | ||
| Q3 25 | $2.8B | $218.4M | ||
| Q2 25 | $3.0B | $216.9M | ||
| Q1 25 | $2.7B | $214.9M | ||
| Q4 24 | — | $208.0M | ||
| Q3 24 | — | $212.3M | ||
| Q2 24 | — | $214.2M | ||
| Q1 24 | — | $209.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $171.0K |
| Free Cash FlowOCF − Capex | $24.1M | $-227.0K |
| FCF MarginFCF / Revenue | 89.9% | -0.9% |
| Capex IntensityCapex / Revenue | 16.0% | 1.6% |
| Cash ConversionOCF / Net Profit | 5.32× | 0.08× |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | $5.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | $171.0K | ||
| Q3 25 | $24.1M | $1.7M | ||
| Q2 25 | $-2.3M | $4.2M | ||
| Q1 25 | $-2.2M | $3.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | $2.8M |
| Q4 25 | $24.1M | $-227.0K | ||
| Q3 25 | $23.3M | $-177.0K | ||
| Q2 25 | $-3.3M | $3.6M | ||
| Q1 25 | $-3.9M | $2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | 89.9% | -0.9% | ||
| Q3 25 | 83.2% | -0.7% | ||
| Q2 25 | -12.8% | 13.1% | ||
| Q1 25 | -16.9% | 9.4% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.2% |
| Q4 25 | 16.0% | 1.6% | ||
| Q3 25 | 3.1% | 7.2% | ||
| Q2 25 | 3.7% | 2.4% | ||
| Q1 25 | 7.2% | 2.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | 5.32× | 0.08× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | -0.60× | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 5.54× | ||
| Q1 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVBC
Segment breakdown not available.
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
